Results 191 to 200 of about 71,992 (213)

Glioblastoma resistance to EGFR antibody-drug conjugate is driven by transcriptional reprogramming and TEK-induced EGFR suppression. [PDF]

open access: yesJ Transl Med
Blomquist MR   +20 more
europepmc   +1 more source

Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors. [PDF]

open access: yesCancer Res Commun
Rohrberg KS   +39 more
europepmc   +1 more source

Alternative splicing generates HER2 isoform diversity underlying antibody-drug conjugate resistance in breast cancer. [PDF]

open access: yesGenome Res
Guardia GDA   +7 more
europepmc   +1 more source

Hodgkin lymphoma: A review and update on recent progress

Ca-A Cancer Journal for Clinicians, 2018
Satish P Shanbhag, Richard F Ambinder
exaly  

Conjugate Additions of Nitroalkanes to Electron-Poor Alkenes:  Recent Results

Chemical Reviews, 2005
Roberto Ballini   +2 more
exaly  

Polymer–drug conjugate therapeutics: advances, insights and prospects

Nature Reviews Drug Discovery, 2018
Iriny Ekladious   +2 more
exaly  

Home - About - Disclaimer - Privacy